Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 18, 2022
Reporting Period: First Quarter 2022
This filing serves as a conduit for a press release titled "IceCure Medical Reports First Quarter 2022 Financial Results and Operational Highlights," which is attached as Exhibit 99.1. The document itself does not contain the detailed financial tables or narrative analysis found in the press release.
Key Financial Metrics
The Form 6-K text provided does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only indicates that such results were reported in the accompanying press release.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These elements are presumed to be detailed in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific Q1 2022 financial figures, as they are absent from the Form 6-K cover page.
- Verify the operational highlights mentioned in the press release title to understand the company's current status.
- Confirm the incorporation of this report into Registration Statements on Form S-8 (File Nos. 333-262620 and 333-264578).
- Check for any subsequent filings that may supersede the information in this report.